Dasotraline Pediatric ADHD Study

Clinical trial NCT02428088 · COMPLETED

Trial details

NCT number: NCT02428088
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder

Start date: 2015-04-01
Primary completion: 2016-07-01
Enrollment: 330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.